𝛼SK or Search

ENTITY

Sirnaomics (2257 HK)

44

Analysis

Health Care • Hong Kong

Sirnaomics is an RNA therapeutics biopharmaceutical company that discovers and develops innovative drugs for indications with unmet medical needs. The company leverages its proprietary polypeptide nanoparticle (PNP) and GalNAc RNAi platforms (GalAhead™) to build a pipeline of drug candidates, including STP705 and STP707 for oncology and fibrosis, and STP122G for anticoagulant therapies. Headquartered in Gaithersburg, MD, United States, the company was founded in 2007.

more

Refresh

Exchange Announcement • 06 Oct 2026 17:00

Discloseable Transaction Supplemental Announcement In Relation To Deemed Disposal Of Equity Interest In A Subsidiary And Grant Of Repurchase Right

Exchange Announcement • 03 Sep 2026 17:01

Interim Report 2026

Exchange Announcement • 28 Aug 2026 19:34

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 26 Aug 2026 19:00

Discloseable Transaction - Deemed Disposal Of Equity Interest In A Subsidiary And Grant Of Repurchase Right

Exchange Announcement • 14 Aug 2026 21:00

Inside Information - Issue Of A Writ Of Summons

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x